Is Saroja Pharma Industries India Ltd (SAROJA) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Saroja Pharma Industries India Ltd is a average quality company .

Is Saroja Pharma Industries India Ltd (SAROJA) undervalued or overvalued?

The key valuation ratios of Saroja Pharma Industries India Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Saroja Pharma Industries India Ltd (SAROJA) share price return in the past 10 years?

Data is not available for this company

Is Saroja Pharma Industries India Ltd (SAROJA) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Saroja Pharma Industries India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Saroja Pharma Industries India Ltd (SAROJA)?

Company share prices are keep on changing according to the market conditions. The current trading price of Saroja Pharma Industries India Ltd (SAROJA) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Saroja Pharma Industries India?

The latest standalone P/E ratio of Saroja Pharma Industries India as of 01-Jan-1970 is 12.83.

What is the P/B ratio of Saroja Pharma Industries India Ltd (SAROJA)?

The latest standalone P/B ratio of Saroja Pharma Industries India Ltd (SAROJA) as of 01-Jan-1970 is 0.85.

What is the 52-week high and low of Saroja Pharma Industries India Ltd (SAROJA)?

The 52-week high of Saroja Pharma Industries India Ltd (SAROJA) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Saroja Pharma Industries India Ltd (SAROJA) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Saroja Pharma Industries India Ltd (SAROJA)
Brand: Saroja Pharma Industries India

Saroja Pharma Industries India Ltd (SAROJA) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Saroja Pharma Industries India Ltd (SAROJA)

BSE: 0 NSE: SAROJA

Key Metrics

Market Cap

₹13 Cr.

P/E Ratio

12.83

Price to Book (P/B)

0.85

Price to Sales (P/S)

0.25

EV/EBITDA

7.53

Return on Capital Employed (ROCE)

12.56%

Current Price

₹0

Return on Equity (ROE)

6.82%

Return on Assets (ROA)

3.13%

Operating Profit Margin

5.2%

Net Profit Margin

1.92%

Gross Profit Margin

2.9%

Book Value per Share

₹39

Sales Growth (YoY)

32.11%

Sales Growth (3 Years)

-1.15%

Operating Profit Growth (1 Year)

8.98%

Operating Profit Growth (3 Years)

9.93%

Net Profit Growth (1 Year)

17.05%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

-3.2%

Dividend Yield

0.00%

Promoter Holding

73.02%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Saroja Pharma Industries India Ltd over the last decade?

Over the last 1 year(s), the stock has delivered a CAGR of -16.77% based on the current price.

Q.1 Which industry/sub-sector does Saroja Pharma Industries India Ltd belong to?

Saroja Pharma Industries India Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Return on capital employed (ROCE) of Saroja Pharma Industries India Ltd?

Saroja Pharma Industries India Ltd Return on capital employed is 12.56% for FY-2025, which is below its 5-year historical median of 22.1%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.1 Promoter shareholding and pledge status of Saroja Pharma Industries India Ltd?

Promoters hold 73.02% of the Saroja Pharma Industries India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Saroja Pharma Industries India Ltd vs industry peers?

Saroja Pharma Industries India Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

DeciZen - make an informed investing decision on Saroja Pharma Ind

Based on:

Data

M-Cap below 100cr DeciZen not available

Saroja Pharma Industries India stock performance

Key Ratios

Is Saroja Pharma Industries India Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	34.6%	33.7%	22.1%	14.9%	12.6%	-
Value Creation Index ⓘ	1.5	1.4	0.6	0.1	-0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	36.7	55.6	50.2	40.7	53.7	54
Sales YoY Gr.	-	51.8%	-9.8%	-19%	32.1%	-
Adj EPS ⓘ	55.6	3.5	3.4	2.1	2.5	2.6
YoY Gr.	-	-93.7%	-2.9%	-37.2%	14.5%	-
BVPS (₹) ⓘ	72	13.7	17.3	36.4	39	39
Adj Net Profit ⓘ	0.7	1	1	0.9	1	1
Cash Flow from Ops. ⓘ	-1.1	-3.7	2.2	1	1.2	-
Debt/CF from Ops. ⓘ	-2.9	-1.7	4.7	5.6	8.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-1.2%	32.1%
Adj EPS ⓘ	NA	NA	-11.3%	14.5%
BVPSⓘ	NA	NA	41.6%	7.1%
Share Price	-	-	-	-16.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	77.3	41.5	22	8.7	6.5	6.6
Op. Profit Mgn % ⓘ	3.6	3.8	5.4	6.3	5.2	NAN
Net Profit Mgn % ⓘ	2	1.9	2	2.1	1.8	1.9
Debt to Equity ⓘ	3.2	1.5	2	0.4	0.6	-
Working Cap Days ⓘ	0	75	115	154	153	0
Cash Conv. Cycle ⓘ	0	41	67	81	77	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	2.6	-
TTM Sales (₹ Cr.)	53.7	-
BVPS (₹) ⓘ	39	-
Reserves (₹ Cr.) ⓘ	12	-
P/BV ⓘ	0.85	-
PE ⓘ	12.83	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	13.3
Equity (₹ Cr.)	4
Face Value (₹)	10
Industry PE ⓘ	43.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Saroja Pharma Ind - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	36.66	55.63	50.19	40.67	53.73
Operating Expenses ⓘ +	35.36	53.53	47.47	38.11	50.94
Manufacturing Costs	1.33	1.86	1.03	1.67	1.52
Material Costs	32.02	48.50	44.31	34	47.09
Employee Cost	0.55	0.73	0.83	0.92	0.74
Other Costs ⓘ	1.47	2.44	1.31	1.52	1.59
Operating Profit ⓘ	1.30	2.10	2.72	2.56	2.79
Operating Profit Margin (%)	3.6%	3.8%	5.4%	6.3%	5.2%
Other Income ⓘ +	0.09	0.32	0.16	0.19	0.19
Exceptional Items ⓘ	0	0	0	0	0
Interest ⓘ	0.33	0.80	1.32	1.45	1.41
Depreciation ⓘ	0.02	0.05	0.07	0.09	0.11
Profit Before Tax ⓘ	1.04	1.58	1.49	1.21	1.45
Tax ⓘ	0.30	0.44	0.43	0.33	0.42
Profit After Tax	0.73	1.14	1.06	0.88	1.03
PAT Margin (%)	2.0%	2.1%	2.1%	2.2%	1.9%
Adjusted EPS (₹)	56.3	3.9	3.6	2.2	2.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.94	4.03	5.09	14.64	15.68
Share Capital ⓘ	0.01	0.23	2.94	4.02	4.02
Reserves ⓘ	0.93	3.80	2.15	10.62	11.66
Debt +	3.02	6.14	10.19	5.74	9.46
Long Term Debt	1.42	1.70	2.81	2.62	1.38
Short Term Debt	1.60	4.44	7.38	3.11	8.08
Minority Interest	0	0	0	0	0
Trade Payables	4.15	5.31	5.86	5.61	13.65
Others Liabilities ⓘ	0.12	0.04	0.20	0.58	0.77
Total Liabilities ⓘ	8.22	15.51	21.34	26.56	39.55
Fixed Assets
Net Fixed Assets ⓘ +	0.09	0.34	2.22	2.51	2.51
Gross Block	0.12	0.42	2.36	2.75	2.86
Accumulated Depreciation	0.03	0.07	0.14	0.23	0.35
CWIP ⓘ	0	0	1.79	6.13	8.61
Investments ⓘ	0	0.04	0.14	0.20	0.34
Inventories	0.66	0.47	3.87	0.40	0.10
Trade Receivables	7.22	13.98	11.11	16.24	26.58
Cash Equivalents	0	0.26	0.36	0.32	0.33
Others Assets ⓘ	0.25	0.42	1.86	0.76	1.08
Total Assets ⓘ	8.22	15.51	21.34	26.56	39.55

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-1.05	-3.67	2.19	1.02	1.15
PBT ⓘ	1.04	1.58	1.49	1.21	1.45
Adjustment ⓘ	0.35	0.84	1.37	1.52	1.49
Changes in Working Capital ⓘ	-2.13	-5.65	-0.25	-1.37	-1.37
Tax Paid ⓘ	-0.30	-0.44	-0.42	-0.33	-0.42
Cash Flow From Investing Activity ⓘ +	-0.05	-0.34	-4.82	-4.76	-2.70
Capex	-0.05	-0.30	-3.73	-0.39	-0.11
Net Investments	0	-0.04	-0.10	-0.06	-0.14
Others ⓘ	0	0	-1	-4.31	-2.45
Cash Flow From Financing Activity ⓘ +	1.03	4.27	2.73	3.70	1.56
Net Proceeds from Shares ⓘ	0	1.95	0	8.68	0
Net Proceeds from Borrowing ⓘ	0	0	1.11	-0.19	-1.24
Interest Paid ⓘ	-0.33	-0.80	-1.32	-1.45	-1.41
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	1.36	3.12	2.94	-3.34	4.21
Net Cash Flow ⓘ	-0.07	0.26	0.10	-0.04	0.01

Finance Ratio

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	78.14	45.95	23.28	8.9	6.82
ROCE (%)	34.59	33.73	22.1	14.91	12.56
Asset Turnover Ratio	4.46	4.69	2.72	1.7	1.63
PAT to CFO Conversion(x)	-1.44	-3.22	2.07	1.16	1.12
Working Capital Days
Receivable Days	71.90	69.60	91.20	122.70	145.50
Inventory Days	6.50	3.70	15.80	19.10	1.70
Payable Days	47.30	35.60	46	61.60	74.60

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Saroja Pharma Industries India Ltd FAQs

The current trading price of Saroja Pharma Ind on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Saroja Pharma Ind stood at ₹13.27 Cr

The latest P/E ratio of Saroja Pharma Ind as of 31-Dec-1969 is 12.83.

The latest P/B ratio of Saroja Pharma Ind as of 31-Dec-1969 is 0.85.

The 52-week high of Saroja Pharma Ind is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Saroja Pharma Ind is ₹53.73 ( Cr.) .

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India was originally incorporated as Private Limited, under the Companies Act, 2013 (Companies Act) in the name and style of ‘Saroja Pharma Industries India Private Limited’ on January 14, 2019 under the provisions of the Companies Act, 2013 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, company was converted into public limited company and due to the conversion, the name of the company name was changed to ‘Saroja Pharma Industries India Limited’ and a fresh Certificate of Incorporation dated April 18, 2023 was issued by the Registrar of Companies, Mumbai, Maharashtra.

The company is amongst the leading traders, exporter and suppliers of Specialty Chemicals. The offered range is widely praised for its superior effectiveness, shelf life and perfect composition. The company was incorporated with the objective of the best service deliverance in chemical trading with the best premium pharmaceutical companies in India and abroad for cost effective human and veterinary medicine. The company trade in Pharma API, Pharma Intermediates, Chemicals, Solvents used for pharmaceutical products human and veterinary medicine. The Company was formed with a mission being providing clientele specification based approved product at a competitive pricing with hassle free dispatch within India or aboard contributing to cost effectiveness in end product for human and veterinary medicine.

The product demand by its clientele is manufactured as per their specifications by its suppliers initially in sample size thereafter on clients testing and approving the order is finalized. The approved specified product is manufactured for the order quantity to be dispatched by the appropriate mode of transport within India or abroad. Since its inception, Saroja Pharma Industries India has witnessed a substantial expansion in its clientele base over the past two years. This growth has propelled the company to venture into the manufacturing of API Pharma products, for veterinary use. By broadening its product portfolio, Saroja Pharma Industries India aims to provide a comprehensive range of pharmaceutical solutions that cater to the diverse needs of its expanding customer base. This strategic move not only enhances the company's value proposition but also reinforces its commitment to delivering affordable healthcare solutions globally.

Business area of the company

The company is engaged into the business of trading of pharma products like pharma API, Pharma Intermediary and Pharma chemicals.

Products of the company

Chemical

Liquid bromine
Ethyl acetate
Thionyl chloride
Para nitro phenol
Toluene N.G
Benzyl chloride

Active Pharmaceutical Ingredient (API)

Oxyclozanide BP Vet
Bromhexine HCL BP Grade
Triclabendazole
Fenbendazole BP Vet
Nitroxynil BP Vet
Oxfendazole BP Vet
Albendazole USP
Rafoxanide BP Vet
Febantel EP

Pharma Intermediary

History and milestones

2019: Incorporation of the company viz. Saroja Pharma Industries India Private Limited.
2023: Conversion of the company’s status from Private Limited to Limited Company to Saroja Pharma Industries India Limited.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Saroja Pharma Industries India Ltd (SAROJA) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating